Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Sepracor Reports Positive Data From Lunesta Trial In Generalized Anxiety

12 May 2008

Firm may be planning to expand the label for its insomnia drug.

Related Content

Sepracor Ends Xopenex Patent Battle, Seals Deals With Arrow

01 May 2008

GSK Gains EU Rights To Lunesta Through Deal With Sepracor

11 Sep 2007

Generic Ambien To Launch Immediately Following FDA Approval

23 Apr 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.